Ipamorelin

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue investigated in laboratory and controlled clinical research for its selective activity at the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor. In experimental systems, Ipamorelin binds GHS-R1a and activates Gq/PLC-dependent calcium signaling pathways that stimulate endogenous growth hormone (GH) release. Due to its receptor specificity, it demonstrates minimal observed activity on other anterior pituitary hormones, including ACTH, prolactin, FSH, LH, TSH, and cortisol under controlled conditions, distinguishing it from earlier-generation secretagogues.

In vitro systems and controlled clinical investigations evaluate endpoints including pulsatile GH secretion dynamics, receptor binding affinity, intracellular calcium mobilization, downstream signaling cascades, and insulin-like growth factor-1 (IGF-1) response patterns relative to controls.